RAPIZZI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.752
EU - Europa 3.447
AS - Asia 2.971
SA - Sud America 416
AF - Africa 78
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.704
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.681
RU - Federazione Russa 1.252
SG - Singapore 870
IT - Italia 810
CN - Cina 713
HK - Hong Kong 506
PL - Polonia 367
BR - Brasile 329
VN - Vietnam 290
KR - Corea 254
IE - Irlanda 243
SE - Svezia 222
FI - Finlandia 116
FR - Francia 114
DE - Germania 98
GB - Regno Unito 77
IN - India 75
BD - Bangladesh 61
JO - Giordania 47
AR - Argentina 40
AU - Australia 39
UA - Ucraina 36
ID - Indonesia 33
CA - Canada 31
CH - Svizzera 31
NL - Olanda 31
MX - Messico 23
IQ - Iraq 20
TR - Turchia 20
JP - Giappone 19
EC - Ecuador 17
BE - Belgio 15
ZA - Sudafrica 14
CI - Costa d'Avorio 13
MA - Marocco 11
PK - Pakistan 11
ES - Italia 10
LT - Lituania 8
NG - Nigeria 8
PY - Paraguay 8
PH - Filippine 7
CL - Cile 6
EG - Egitto 6
KE - Kenya 6
NP - Nepal 6
UZ - Uzbekistan 6
VE - Venezuela 6
BJ - Benin 5
AZ - Azerbaigian 4
CO - Colombia 4
RO - Romania 4
SA - Arabia Saudita 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
GA - Gabon 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
NI - Nicaragua 3
PE - Perù 3
TN - Tunisia 3
TW - Taiwan 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AT - Austria 2
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
MY - Malesia 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BY - Bielorussia 1
ET - Etiopia 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
MV - Maldive 1
PT - Portogallo 1
RE - Reunion 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.704
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.052
Ashburn 824
Singapore 687
Fairfield 533
Hong Kong 455
Warsaw 364
Woodbridge 255
Seoul 251
Dublin 243
Chandler 225
Cambridge 207
San Jose 202
Seattle 195
Hefei 180
Wilmington 180
Houston 177
Beijing 165
Milan 144
Ann Arbor 108
Altamura 98
Lawrence 98
Florence 96
Los Angeles 83
Ho Chi Minh City 79
Buffalo 75
Rome 71
Lauterbourg 70
Council Bluffs 67
Hanoi 67
Moscow 67
Princeton 64
The Dalles 58
Jacksonville 52
Helsinki 50
New York 50
Munich 45
Boston 44
Mumbai 41
Boardman 36
Melbourne 34
Dallas 33
Medford 33
Kent 32
Paris 30
Shanghai 30
Jakarta 28
San Diego 28
Bern 25
Chicago 23
São Paulo 22
Guangzhou 19
Bologna 18
Haiphong 18
Orem 18
Tokyo 18
Naples 17
Turin 17
Lappeenranta 15
Redondo Beach 15
Brussels 14
Rio de Janeiro 14
Abidjan 13
Brooklyn 13
Figino 13
Venice 13
Chennai 12
Da Nang 12
London 12
Montreal 12
Turku 12
West Jordan 12
Falls Church 11
Hillsboro 11
Dong Ket 10
Mexico City 10
Norwalk 10
Stanford 10
Yubileyny 10
Clifton 9
Curitiba 9
Frankfurt am Main 9
Guayaquil 9
Izmir 9
Salt Lake City 9
Toronto 9
Abuja 8
Phoenix 8
Redmond 8
Redwood City 8
Ankara 7
Belo Horizonte 7
Bengaluru 7
Casablanca 7
Haarlem 7
Johannesburg 7
Palermo 7
Shenzhen 7
Verona 7
Amsterdam 6
Baghdad 6
Totale 8.625
Salva come PNG Salva come JPEG
Nome #
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 296
Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. 289
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 266
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function 263
miR-210-3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5-fluorouracil 247
A unique neuroendocrine cell model derived from the human foetal neural crest. 236
Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomas. 231
Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas. 225
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 219
Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis 217
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 217
The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide 201
Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription 197
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 196
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 194
ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. 191
Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts 188
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 185
Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. 185
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 182
[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation 180
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 178
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma 175
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 172
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 172
Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men 171
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma 170
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 169
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma 169
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 169
Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function 168
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 167
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 166
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland 165
The regulatory effect of sex steroids on the RhoA/ROCK pathway in the rat distal vagina 163
Clinical relevance of phenotype/genotype correlations in the diagnosis and therapy of pheochromocytomas/paragangliomas. 162
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 162
Functional significance of germline EPAS1 variants 162
Correction for age of anticardiolipin antibodies cut-off points. 159
SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism 159
Tumour microenvironment in pheochromocytoma and paraganglioma 158
Antiphospholipid antibody syndrome and polymyalgia rheumatica/giant cell arteritis. 158
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 156
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma 156
Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency. 155
Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool 153
Pheochromocytoma/paraganglioma preclinical models: which to use and why? 153
The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. 153
Loss of sdhb in zebrafish larvae recapitulates human paraganglioma characteristics 151
Analysis of telomere maintenance related genes reveals NOP10 as a new metastatic-risk marker in pheochromocytoma/paraganglioma 149
Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. 147
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas 145
Distal vagina smooth muscle contractility mechanisms: effects of in vivo sex steroids treatment in an animal experimental model of ovariectomy 144
Tumor necrosis factor-α exerts promyogenic action in C2C12 myoblasts via sphingosine kinase/S1P2 signaling. 143
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 143
Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells 141
INHIBITION OF POLY(ADP-RIBOSE) GLYCOHYDROLASE BY GALLOTANNIN SELECTIVELY UP-REGULATES EXPRESSION OF PRO-INFLAMMATORY GENES. 140
Sphingosine 1-phosphate inhibits cell migration in C2C12 myoblasts 138
Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. 135
Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts 134
Sphingosine 1-phosphate receptors modulate intracellular Ca2+ homeostasis 130
Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s) released by activated monocytes. 128
A role for calcium in Bcl-2 action? 128
Pitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas-Case Report. 125
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 125
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas 120
Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor. 120
Recombinant aequorin and green fluorescent protein as valuable tools in the study of cell signalling. 120
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma 118
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. 117
Malignant Pheochromocytoma 115
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients 111
Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction. 108
TGFbeta protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation. 107
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas 104
Pros and cons of surgical versus conservative management for head and neck paraganglioma: a real-world data analysis 102
Outcome of fifty-five newborns of antiphospholipid antibody-positive mothers treated with calcium heparin during pregnancy. 88
Preclinic and Translational Research in Adrenal Malignancies 73
Presurgical Succinate MetAstatic Risk Tool (P-SMART) in Paragangliomas 41
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy. 19
Totale 12.834
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022479 14 47 57 16 17 27 18 47 11 30 70 125
2022/20231.196 96 280 54 73 74 185 148 49 134 26 45 32
2023/2024577 14 54 76 36 45 66 19 135 30 42 44 16
2024/20253.504 104 368 217 586 896 431 112 272 88 99 161 170
2025/20264.591 489 649 436 376 505 166 531 220 263 257 143 556
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 12.834